x
Marksman Healthcare
[contact-form-7 id="2459" title="Sidebar Form"]

  • Bulls Stadium, California
  • 666-888-0000
  • info@example.com
Marksman Healthcare
  • Home
  • About Us
  • Services
    • HEOR
    • RWE
    • Value Communications
    • Competitive Intelligence
  • Case studies
  • Publications
  • Key Highlights
  • Blog
  • MarksMan Academy
  • Contact Us
Marksman Healthcare
  • Contact Us
Logo

Contact Info

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • +91-9160467576
  • enquiry@marksmanhealthcare.com

Category: Healthcare Policy

    Marksman Healthcare > Blog > Healthcare Policy

09Apr

How India’s DISHA is Different from Global Patient Data Protection Laws?

by MarksMan Healthcare,  0 Comments

Currently, the data protection law in India is facing many issues due to the absence of proper legislative framework. The theft and sale of stolen data is happening across vast […]

Read More

30Dec

Why pharmaceutical Companies are Prioritising Multi-Indication Drugs?

by MarksMan Healthcare,  0 Comments

Early stage drug candidates are increasingly being recognized to have potential applications in several therapy areas; especially in case of several diseases with a similar etiology. Illnesses associated with immunology, […]

Read More

26Apr

Facts & Fiction – Branded v/s Generic Controversy – India

by MarksMan Healthcare,  0 Comments

All branded drugs are of good quality – Fiction Majority of the branded drugs are of good quality – Fact All generic drugs are of good quality – Fiction Majority […]

Read More

25Apr

Is India Gearing up for Patient Centric Healthcare Model?

by MarksMan Healthcare,  0 Comments

Following the recent announcement by PM Narendra Modi hinting at a legal framework for doctors to prescribe generic medicines cheaper than equivalent branded generic drugs, doctors appeared to welcome the […]

Read More

07Feb

Use of QALY in Healthcare Decision-Making – The Controversy Continues

by MarksMan Healthcare,  0 Comments

In many parts of the world, the value of medicines is measured by a unit called ‘Quality-Adjusted Life Year’ (QALY), a metric that health economists and others use to quantify […]

Read More

24Nov

Patient Preference Studies: Can They Replace RCTs?

by MarksMan Healthcare,  0 Comments

While scientists, clinicians, and regulators play critical roles in understanding and communicating the benefits and risks of drugs/medical treatments, only patients live with their medical conditions and make choices regarding […]

Read More

30Sep

EBM and HTA for Healthcare Decision Making – The Time has Come!

by MarksMan Healthcare,  0 Comments

Health systems have developed at different speeds, and with differing degrees of complexity throughout the twentieth century, reflecting the diverse political and social conditions in each country. Notwithstanding their diversity, […]

Read More

26Sep

Cost Effectivity or Affordability: What Should be Prioritized in India?

by MarksMan Healthcare,  0 Comments

Rapidly rising cost in healthcare is an increasing cause of concern across the world. Indian healthcare is also experiencing a change, with increasing focus on better quality of medical care […]

Read More

Your Partner in Evidence
Synthesis and Market Access

Book Free Sampling Here

Latest Blogs

Quick links

Work with us

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • Call Us: +91-9160467576
  • enquiry@marksmanhealthcare.com

Single Arm Trials in HTA: Navigating Assessment Pathways

December 1, 2023

Generating Regulatory-Grade Real-World Evidence: Tools and Frameworks

November 10, 2023

Using Individual Participant Data for Network Meta-Analysis: Advantages and Challenges

October 19, 2023

  • About Us
  • Our Services
  • Case Studies
  • Publications
  • Careers
  • Contact Us
  • Policy

We believe that work is to be pursued and enjoyed through commitment, teamwork, creative thinking, and an ethical approach in everything we do. Apply HERE about openings

HEOR, RWE, and Market Access Consulting

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • Call Us: +91-9160467576
  • enquiry@marksmanhealthcare.com

Latest Blogs

Single Arm Trials in HTA: Navigating Assessment Pathways

December 1, 2023

Generating Regulatory-Grade Real-World Evidence: Tools and Frameworks

November 10, 2023

Using Individual Participant Data for Network Meta-Analysis: Advantages and Challenges

October 19, 2023

Quick links

  • About Us
  • Our Services
  • Case Studies
  • Publications
  • Careers
  • Contact Us
  • Policy

Work with us

We believe that work is to be pursued and enjoyed through commitment, teamwork, creative thinking, and an ethical approach in everything we do. Apply HERE about openings

Copyright © 2023 Marksman Healthcare Communications Crafted by LUBUS

 

Loading Comments...